Candel Therapeutics Ownership | Who Owns Candel Therapeutics?
Candel Therapeutics Ownership Summary
Candel Therapeutics is owned by 41.99% institutional investors, 20.83% insiders, and 37.17% retail investors. Fmr is the largest institutional shareholder, holding 12.26% of CADL shares. Fidelity Select Biotechnology is the top mutual fund, with 11.74% of its assets in Candel Therapeutics shares.
CADL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Candel Therapeutics | 41.99% | 20.83% | 37.17% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 3.92M | 12.26% | $34.06M |
| Baker bros. advisors lp | 2.98M | 9.31% | $25.88M |
| Northpond ventures | 1.94M | 6.63% | $12.00M |
| Vanguard group | 1.34M | 4.18% | $11.62M |
| Blackrock funding, inc. /de | 1.18M | 3.70% | $10.28M |
| Blackrock | 823.07K | 2.82% | $5.10M |
| Portolan capital management | 753.75K | 2.35% | $6.54M |
| Halter ferguson financial | 681.33K | 2.13% | $5.91M |
| State street | 560.97K | 1.75% | $4.87M |
| Geode capital management | 455.42K | 1.42% | $3.95M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Northpond ventures | 1.94M | 21.71% | $12.00M |
| Halter ferguson financial | 681.33K | 2.42% | $5.91M |
| Sands capital ventures | 405.84K | 0.77% | $3.52M |
| Portolan capital management | 753.75K | 0.44% | $6.54M |
| Birchview capital, lp | 60.00K | 0.42% | $520.80K |
| Baker bros. advisors lp | 2.98M | 0.28% | $25.88M |
| Virtu financial | 22.64K | 0.01% | $140.00K |
| Hb wealth management | 87.30K | 0.01% | $696.19K |
| Fmr | 3.92M | 0.00% | $34.06M |
| Mml investors services | 49.23K | 0.00% | $427.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 3.92M | 0.00% | 3.92M |
| Baker bros. advisors lp | 2.98M | 0.28% | 2.98M |
| Blackrock | 823.07K | 0.00% | 775.49K |
| Portolan capital management | 753.75K | 0.44% | 753.75K |
| Vanguard group | 1.34M | 0.00% | 392.88K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -1.60M |
| Bridgeway capital management | - | - | -77.19K |
| Maven securities | - | - | -51.73K |
| Oppenheimer | - | - | -37.91K |
| Mariner | - | - | -33.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Baker bros. advisors lp | 2.98M | 0.28% | 2.98M | $25.88M |
| Portolan capital management | 753.75K | 0.44% | 753.75K | $6.54M |
| Birchview capital, lp | 60.00K | 0.42% | 60.00K | $520.80K |
| Commonwealth equity services | 41.10K | 0.00% | 41.10K | $357.00K |
| Cubist systematic strategies | 26.12K | 0.00% | 26.12K | $161.95K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -1.00 |
| National bank of canada /fi/ | -3.00 |
| Point72 asia (singapore) pte. | -813.00 |
| Ikarian capital | -1.40K |
| Point72 (difc) | -4.93K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 88 | 12.82% | 21,199,863 | 18.25% | 41 | 1.34% | 63 | 16.67% | 12 | 50.00% |
| Dec 31, 2024 | 22 | -60.71% | 2,942,258 | -56.04% | 9 | 2.10% | 15 | -51.61% | 4 | -60.00% |
| Sep 30, 2024 | 56 | 14.29% | 6,693,231 | 12.27% | 20 | 5.01% | 31 | -26.19% | 10 | 150.00% |
| Jun 30, 2024 | 49 | 157.89% | 5,961,761 | 57.71% | 20 | 11.96% | 42 | 366.67% | 4 | -20.00% |
| Mar 31, 2024 | 19 | -9.52% | 3,780,258 | -6.13% | 13 | 6.74% | 9 | - | 5 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 5.54M | 11.74% | - |
| Vanguard Total Stock Mkt Idx Inv | 866.65K | 1.76% | - |
| iShares Russell 2000 ETF | 713.34K | 1.42% | 348.00 |
| Fidelity Growth Compy Commingled Pl S | 657.13K | 1.39% | 356.13K |
| Strategic Advisers U.S. Total Stock | 531.40K | 1.13% | 44.51K |
| Fidelity Growth Company Fund | 497.37K | 1.05% | 260.67K |
| Vanguard Institutional Extnd Mkt Idx Tr | 489.52K | 0.99% | - |
| BANOR SICAV Rosemary S EUR Acc | 360.00K | 0.76% | -39.13K |
| iShares Russell 2000 Growth ETF | 243.21K | 0.49% | - |
| Fidelity Small Cap Index | 215.13K | 0.46% | 12.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 18, 2025 | Nichols William Garrett | Chief Medical Officer | Sell | $397.00K |
| Mar 18, 2025 | Barone Francesca | Chief Scientific Officer | Sell | $281.67K |
| Mar 18, 2025 | Tak Paul Peter | Chief Executive Officer | Sell | $226.02K |
| Mar 19, 2025 | Tak Paul Peter | Chief Executive Officer | Sell | $3.60K |
| Mar 17, 2025 | Tyagarajan Seshu | Chief Technology Officer | Sell | $275.95K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 16 |
| 2024 Q4 | 2 | 10 |
| 2024 Q3 | - | 10 |
| 2024 Q2 | - | - |
CADL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools